EASDelearning

@EASDelearning

We are building a suite of e-learning modules designed to educate, inform and engage healthcare professionals around the world.

Vrijeme pridruživanja: studeni 2019.

Tweetovi

Blokirali ste korisnika/cu @EASDelearning

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EASDelearning

  1. Prikvačeni tweet
    11. stu 2019.

    Our e-learning courses help healthcare professionals keep their knowledge of treatment and management up to date, with modules featuring experts in their fields. Sign up now for a free account:

    Poništi
  2. Watch Professor Mikael Knip of introduce our course on the incidence and diagnosis of type 1 . It’s free to sign up for an account.

    Poništi
  3. proslijedio/la je Tweet
    4. velj

    If you would like information on accessing technology such as pumps, continuous glucose monitors & flash glucose monitors, visit ’s Treatments and Technologies information page or contact .

    Prikaži ovu nit
    Poništi
  4. prije 4 sata

    Test your knowledge on treatment and management of diabetic foot disease with our module. It’s free to sign up for an account.

    Poništi
  5. prije 7 sati

    Our course on cardiovascular health covers historic and contemporary study data and what this can tell us about cardiovascular risk for people with . Sign up for a free account.

    Poništi
  6. proslijedio/la je Tweet
    4. velj
    Poništi
  7. proslijedio/la je Tweet
    prije 10 sati

    To help deliver the next phase of access in Specialist centres: please fill in the questionnaire sent There will be provision of education: Via online modules/ face to face education days/ reading material

    Poništi
  8. proslijedio/la je Tweet
    4. velj

    How do variations in access to technology make you feel? Learn more about the findings in JDRF's new report:

    Poništi
  9. proslijedio/la je Tweet
    , , i još njih 7
    Poništi
  10. proslijedio/la je Tweet
    31. sij

    NEWS!!!! Oral Semaglutide ()gets the green light for Europe (including U.K.) for treatment of "insufficiently controlled to improve glycaemic control."

    Poništi
  11. 31. sij

    Check your knowledge on the management of hyperglycaemia in type 2 with our module on the / consensus report, now with 2019 update.

    Poništi
  12. proslijedio/la je Tweet
    31. sij

    Learnt so much writing this article about the gaps in risk assesment and care models for managing diabetes and cardiovascular disease in south asians

    Prikaži ovu nit
    Poništi
  13. 31. sij

    Ramadan begins in April 2020. This module helps you support patients with who are fasting during the Holy month. It’s free to sign up for an account.

    Poništi
  14. 31. sij

    Our platform has been designed with international experts in the field, using innovative multimedia and challenging knowledge checks to help you to learn more about the fast-moving area of . Sign up now for a free account.

    Poništi
  15. proslijedio/la je Tweet
    28. sij

    Our 2020 Standards of Care includes updates from our recent consensus report w/ on the mgmt. of hyperglycemia in people w/ . Read the report:

    Poništi
  16. 31. sij

    Our course on cardiovascular health and covers this important aspect of management for type 1 and type 2 diabetes. Sign up now for a free account.

    Poništi
  17. proslijedio/la je Tweet
    31. sij
    Poništi
  18. 30. sij

    Do you know your Five Finger Rule when it comes to treating Diabetic Kidney Disease? Test your knowledge with our course covering and the kidney. It’s free to sign up for an account.

    Poništi
  19. proslijedio/la je Tweet
    30. sij

    The umbrella review that is relevant to our commentary in the . It has the limitations that are usual to umbrella reviews, but the advantage of including old as well as new glucose lowering agents. Interesting findings. T2

    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet

    Comment: Srikanth Bellary, Abd Tahrani & Anthony Barnett on: Evidence-based prescribing of medications: are we getting closer?

    Poništi
  21. 30. sij

    Check your knowledge with our module covering the renal outcomes of major SGLT-2 trials, with particular emphasis on the results of the CREDENCE trial. Sign up now for a free account.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·